Nikolai Strusberg, MD, discussed other toxicities of proton vs photon breast RT, practice implications, and next steps in ...
The FDA has approved Enspryng (satralizumab-mwge) for thyroid eye disease in adults, offering the first at-home subcutaneous IL-6 receptor antagonist for TED.
Nationwide initiative brings thyroid awareness, health education, targeted TSH screening and referral closer to the community ...
The FDA approved satralizumab-mwge (Enspryng; Genentech) on October 15, 2026, for adults with thyroid eye disease (TED) ...
The FDA approved Enspryng, an interleukin-6 inhibitor, for at-home subcutaneous treatment of thyroid eye disease, according ...
An updated guideline proposed several shifts in how healthcare professionals manage thyroid health for pregnant women.In May, ...
I checked into The Vessyl, a new Costa Rica wellness resort using 4D sound, vibration and somatic practices for a nervous ...
I checked into The Vessyl, a new wellness resort near Costa Rica's Arenal Volcano, to try its 4D sound dome, somatic ...
At AAO 2026, Michael T. Yen, MD, reviewed REVEAL-1 efficacy and hearing safety data for subcutaneous elegrobart in active TED ...
On Sept. 24, 2026, numerous U.S. lawmakers, human rights leaders, and representatives of non-governmental organizations held a rally with more than 300 Falun Gong practitioners, calling for an end to ...
A recent nationwide thyroid medication recall has been upgraded by the Food and Drug Administration to the agency's highest risk level, with FDA officials warning the "superpotent" drug could "cause ...
A thyroid medicine is being recalled at the FDA's highest risk level − and it's causing confusion and concern among the many Americans who use such medications to manage thyroid conditions. The recall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results